Medicare Enrolled
Dr. Chakra Chaulagain, MD
Hematology & Oncology · Weston, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chaulagain from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chaulagain?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chaulagain
Dr. Chakra Chaulagain is a hematology & oncology specialist in Weston, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Chaulagain performed 21,784 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Chaulagain received a total of $166,655 from 44 pharmaceutical and/or device companies across 306 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chaulagain is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 22% volume in FL
$166,655 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 119743 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗21,784
Medicare services
Top 22% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
20,700 | $37 | $179 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
315 | $133 | $404 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
151 | $59 | $274 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
148 | $97 | $305 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
102 | $7 | $175 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
73 | $99 | $444 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
57 | $103 | $743 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
48 | $12 | $116 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
44 | $12 | $134 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
43 | $16 | $129 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
41 | $50 | $392 |
| New patient office visit, complex (60-74 min) | 28 | $167 | $634 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
19 | $145 | $776 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $130 | $526 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.6% high complexity
96.6% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$166,655
Total received (2018-2024)
Avg $23,808/year across 7 years
Top 6% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
306
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$24,412
2023
$38,138
2022
$44,596
2021
$21,252
2020
$10,395
2019
$13,188
2018
$14,673
Payments by company (2024)
Janssen Biotech, Inc.
$16,701
GENZYME CORPORATION
$3,587
E.R. Squibb & Sons, L.L.C.
$2,130
Janssen Research & Development, LLC
$745
PFIZER INC.
$352
GlaxoSmithKline, LLC.
$141
Daiichi Sankyo Inc.
$112
Novartis Pharmaceuticals Corporation
$85
AstraZeneca Pharmaceuticals LP
$75
TAIHO ONCOLOGY, INC.
$66
Takeda Pharmaceuticals U.S.A., Inc.
$56
BeiGene USA, Inc.
$50
Stemline Therapeutics Inc.
$50
Astellas Pharma US Inc
$41
Merck Sharp & Dohme LLC
$32
Regeneron Healthcare Solutions, Inc.
$27
TerSera Therapeutics LLC
$24
SERVIER PHARMACEUTICALS LLC
$23
Genentech USA, Inc.
$23
Cumberland Pharmaceuticals, Inc.
$22
Tempus AI, Inc
$21
EMD Serono, Inc.
$20
Eisai Inc.
$16
Janssen Scientific Affairs, LLC
$12
Top 3 companies account for 91.8% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$69,211
Janssen Biotech, Inc.
$54,903
PFIZER INC.
$8,235
E.R. Squibb & Sons, L.L.C.
$6,278
BeiGene USA, Inc.
$3,410
Incyte Corporation
$3,402
Agios Pharmaceuticals, Inc.
$2,786
Apellis Pharmaceuticals, Inc.
$2,378
Blueprint Medicines Corporation
$2,340
Seattle Genetics, Inc.
$1,920
Janssen Scientific Affairs, LLC
$1,780
CTI BioPharma Corp.
$1,748
Karyopharm Therapeutics Inc.
$1,550
Janssen Global Services, LLC
$1,500
Epizyme, Inc.,
$1,250
Rigel Pharmaceuticals, Inc.
$1,020
Janssen Research & Development, LLC
$745
AstraZeneca Pharmaceuticals LP
$600
Celgene Corporation
$271
GlaxoSmithKline, LLC.
$206
Novartis Pharmaceuticals Corporation
$204
Daiichi Sankyo Inc.
$112
Takeda Pharmaceuticals U.S.A., Inc.
$101
TAIHO ONCOLOGY, INC.
$88
Astellas Pharma US Inc
$72
Merck Sharp & Dohme LLC
$65
Aurobindo Pharma USA, Inc.
$57
Stemline Therapeutics Inc.
$50
EMD Serono, Inc.
$49
Genentech USA, Inc.
$41
Eisai Inc.
$32
Regeneron Healthcare Solutions, Inc.
$27
TerSera Therapeutics LLC
$24
SERVIER PHARMACEUTICALS LLC
$23
Cumberland Pharmaceuticals, Inc.
$22
Genentech, Inc.
$21
Tempus AI, Inc
$21
Pharmacyclics LLC, An AbbVie Company
$21
Seagen Inc.
$19
Lilly USA, LLC
$17
PUMA BIOTECHNOLOGY, INC.
$17
Bayer Healthcare Pharmaceuticals Inc.
$17
Acrotech Biopharma LLC
$14
SANOFI-AVENTIS U.S. LLC
$9
Top 3 companies account for 79.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · ADVATE · AYVAKIT · Alecensa · BELEODAQ · BLENREP · BOSULIF · BRUKINSA · Beleodaq · CABLIVI · CALQUENCE · CERDELGA · CEREZYME · CYRAMZA · DARZALEX · DISEASE STATE · ELREXFIO · ELZONRIS · ENJAYMO · ERLEADA · Empaveli · Enhertu · FABRAZYME · Fabhalta · Folotyn · GAZYVA · ICLUSIG · IDHIFA · IMBRUVICA · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · LIBTAYO · LONSURF · LUTATHERA · Lenvima · MAVENCLAD · MEKINIST · MONJUVI · NERLYNX · NO PRODUCT DISCUSSED · OJJAARA · OXBRYTA · PADCEV · PEMAZYRE · PYRUKYND · Pomalyst · REBLOZYL · Revlimid · SANCUSO · SARCLISA · SCEMBLIX · SPRYCEL · Stivarga · TAZVERIK · TECVAYLI · Tavalisse · Tecentriq · VONVENDI · VPRIV · Vanflyta · Vonjo · Vyloy · WAINUA · XALKORI · XPOVIO · Xospata · Zoladex
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
155
County median income
$74,534
Nearest hospital to ZIP centroid (approximate)
CLEVELAND CLINIC HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chaulagain is a mixed practice specialist, with above-average Medicare volume (top 22% in FL), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chaulagain experienced with daratumumab injection (darzalex)?
Based on Medicare claims data, Dr. Chaulagain performed 20,700 daratumumab injection (darzalex) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Chaulagain receive payments from pharmaceutical companies?
Yes. Dr. Chaulagain received a total of $166,655 from 44 companies across 306 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chaulagain's costs compare to other hematology & oncology specialists in Weston?
Dr. Chaulagain's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chaulagain) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Weston
Browse hematology & oncology specialists in Weston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology